1.	F18PET/CT Versus TC-MDP Scanning to Detect Bone Mets Phase: Phase III Type: Diagnostic Status: Active Age: 18 and over Sponsor: Other Protocol IDs: AMI-2008-01, NCT00882609
2.	18F-NaF PET in Detecting Metastatic Bone Lesion for Patients With Cancer. Phase: No phase specified Type: Diagnostic Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 941220, NCT00414934
3.	Combined F18 and F18 FDG PET/CT for Evaluation of Malignancy Phase: No phase specified Type: Diagnostic Status: Active Age: Over 18 Sponsor: Other Protocol IDs: VAR0024, 98043, SU-07232008-1266, NCT00725387
4.	Detection of Bone Metastases From Prostate Cancer by PET/CT Phase: No phase specified Type: Diagnostic Status: Active Age: Not specified Sponsor: Other Protocol IDs: KNOPET NMA k 28, NCT00956163
5.	Diagnosis of Bone Metastases in Breast Cancer: Bone Scintigraphy, Fluoride-PET and FDG-PET Phase: No phase specified Type: Diagnostic Status: Active Age: 18 and over Sponsor: Other Protocol IDs: H-3-2010-019, NCT01224873
6.	Imaging of Prostate and Breast Cancer Bone Metastases Using Magnetic Resonance Imaging and Nuclear Medicine Techniques Phase: No phase specified Type: Diagnostic Status: Active Age: 40 to 80 Sponsor: Other Protocol IDs: 113/180/2010, NCT01339780
7.	Sodium Flouride (NaF) Positron Emission Tomograpy/Computed Tomography (PET/CT) in Patients With Metastatic Castrate-resistant Prostate Cancer (CRPC) With Docetaxel-Based Chemo or AR-directed Therapy Phase: No phase specified Type: Diagnostic Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CO11811, NCT01516866
8.	Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer Phase: No phase specified Type: Diagnostic Status: Active Age: 18 and over Sponsor: Other Protocol IDs: VAR0074, NCI-2012-00138, SU-02162012-9128, NCT01541358